Literature DB >> 22840966

Guards of the great wall: bacterial lysozyme inhibitors.

Lien Callewaert1, Joris M Van Herreweghe, Lise Vanderkelen, Seppe Leysen, Arnout Voet, Chris W Michiels.   

Abstract

Peptidoglycan is the major structural component of the bacterial cell wall. It provides resistance against turgor and its cleavage by hydrolases such as lysozymes results in bacteriolysis. Most, if not all, animals produce lysozymes as key effectors of their innate immune system. Recently, highly specific bacterial proteinaceous lysozyme inhibitors against the three major animal lysozyme families have been discovered in bacteria, and these may represent a bacterial answer to animal lysozymes. Here, we will review their properties and phylogenetic distribution, present their structure and molecular interaction mechanism with lysozyme, and discuss their possible biological functions and potential applications.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22840966     DOI: 10.1016/j.tim.2012.06.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  34 in total

1.  Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

Authors:  Meritxell García-Quintanilla; Marina R Pulido; Patricia Moreno-Martínez; Reyes Martín-Peña; Rafael López-Rojas; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

2.  Structural basis of bacterial defense against g-type lysozyme-based innate immunity.

Authors:  S Leysen; L Vanderkelen; S D Weeks; C W Michiels; S V Strelkov
Journal:  Cell Mol Life Sci       Date:  2012-10-21       Impact factor: 9.261

3.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

4.  Crystal structure of bacteriophage T4 Spackle as determined by native SAD phasing.

Authors:  Ke Shi; Fredy Kurniawan; Surajit Banerjee; Nicholas H Moeller; Hideki Aihara
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-08-25       Impact factor: 7.652

5.  Edwardsiella tarda MliC, a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy.

Authors:  Mo-Fei Li; Chong Wang; Li Sun
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

6.  PhiA, a Peptidoglycan Hydrolase Inhibitor of Brucella Involved in the Virulence Process.

Authors:  Mariela G Del Giudice; Alexis M Romani; Juan E Ugalde; Cecilia Czibener
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

7.  Effect of Lipidation on the Localization and Activity of a Lysozyme Inhibitor in Neisseria gonorrhoeae.

Authors:  Stephanie A Ragland; Mary C Gray; Elizabeth M Melson; Melissa M Kendall; Alison K Criss
Journal:  J Bacteriol       Date:  2020-03-26       Impact factor: 3.490

Review 8.  Activation of the extracytoplasmic function σ factor σV by lysozyme.

Authors:  Theresa D Ho; Craig D Ellermeier
Journal:  Mol Microbiol       Date:  2019-07-18       Impact factor: 3.501

9.  Genetically enhanced lysozyme evades a pathogen derived inhibitory protein.

Authors:  Sarah M Dostal; Yongliang Fang; Jonathan C Guerrette; Thomas C Scanlon; Karl E Griswold
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

10.  Lipoprotein LprI of Mycobacterium tuberculosis Acts as a Lysozyme Inhibitor.

Authors:  Deepti Sethi; Sahil Mahajan; Chaahat Singh; Amrita Lama; Mangesh Dattu Hade; Pawan Gupta; Kanak L Dikshit
Journal:  J Biol Chem       Date:  2015-11-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.